Assessment of glioma treatment is based on pathological evaluation via biopsies or radiological criteria using follow-up MRI, which is either invasive or time consuming. Amide protein transfer weighted (APTw) MRI has been validated to accurately detect recurrent malignant gliomas by multiple studies. The cutting edge methodology of radiomics provides quantitative measurements for imaging diagnosis. Here, we develop an automated framework that integrates APTw MRI radiomic features with a machine learning model to evaluate treatment response for gliomas. Our results suggest that the use of APTw features enabled the radiomic model to reach a more accurate assessment of the treatment effect.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords